Pfizer CentreOne Capabilities Update March 2026: Small Molecule Drug Product

At Pfizer CentreOne, we simplify complexity to meet your oral solid dose (OSD) development and manufacturing needs, drawing on decades of scientific expertise from Pfizer and a proven track record of delivering high-quality products. Our experience spans highly potent, cytotoxic, controlled-release, and low-bioavailability compounds, enabling us to support even the most challenging programs with confidence.

Leveraging specialized technologies such as laser drilling, multilayer coating, and orally disintegrating tablet (ODT) platforms, along with state-of-the-art facilities, we provide the precision, flexibility, and scalability required to bring complex OSD products to market. From development through commercial supply, our integrated capabilities and rigorous quality standards ensure reliable execution and consistent performance at every stage.